Excimer Laser Eye Center is categorized under Internal Medicine Doctors in Pensacola, FL and active since 2007.
Excimer Laser Eye Center was established in 2007, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Pete Keiek at the company’s single location by writing to 8333 North Davis Highway, Pensacola, Florida FL 32514 or by phoning (850) 969-2020. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Excimer Laser Eye Center |
| Contact Person: | Pete Keiek |
| Address: | 8333 North Davis Highway, Pensacola, Florida 32514 |
| Phone Number: | (850) 969-2020 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6214930 |
| Share This Business: |
Excimer Laser Eye Center was started in 2007 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Pete Keiek for inquiries that concern Excimer Laser Eye Center by calling the company number (850) 969-2020, as your correspondence is most welcome. Additionally, the physical location of the single location of Excimer Laser Eye Center can be found at the coordinates 30.51344,-87.21844 as well as the street address 8333 North Davis Highway in Pensacola, Florida 32514.
For its online presence, you may visit Excimer Laser Eye Center’s website at and engage with its social media outlets through on Twitter and on Facebook.